Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ)
CNY 5.67
(2.35%)
CNY 5.67
(2.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -383.3 Million | -64.33 Million | 11.79 Million | 128.3 Million | 255.07 Million | 73.29 Million |
| Net Income | -347.73 Million | -320.69 Million | -491.19 Million | 14.82 Million | -516.55 Million | -874.95 Million |
| Depreciation & Amortization | 98.22 Million | 95.81 Million | 116.36 Million | 123.87 Million | 142.88 Million | 159.08 Million |
| Deferred income taxes | -26.71 Million | 73.16 Million | -48.37 Million | -13.42 Million | -50.84 Million | -55.02 Million |
| Stock-based compensation | 421.96 Thousand | 9.65 Million | - | - | - | - |
| Change in working capital | -266.42 Million | 82.28 Million | 9.62 Million | 568.01 Thousand | 47.36 Million | -31.84 Million |
| Other non-cash items | 27.5 Million | -4.57 Million | 376.99 Million | -10.95 Million | 581.37 Million | 821 Million |
| Investing Cash Flow | -536.78 Million | -9.75 Million | -95.21 Million | 220.65 Million | -78.27 Million | -108.03 Million |
| Investments in PPE | -468.35 Million | -31.09 Million | -88.87 Million | -107.72 Million | -91.92 Million | -118.07 Million |
| Acquisitions | -49.63 Million | 7.35 Million | 3.66 Million | 258.19 Million | 15.8 Million | 10.04 Million |
| Investment purchases | - | -37.6 Million | -10 Million | - | - | - |
| Sales/Maturities of investments | - | -7.35 Million | -3.66 Million | - | - | - |
| Other Investing Activities | -21 Million | 58.93 Million | 3.66 Million | 70.18 Million | -2.14 Million | 10.04 Million |
| Financing Cash Flow | 925.94 Million | 47.82 Million | -109.45 Million | -266.25 Million | -118.85 Million | 2.8 Million |
| Debt repayment | -522.87 Million | -82 Million | -172.07 Million | -364.29 Million | -380.79 Million | -620.56 Million |
| Dividends payments | -12.06 Million | -5.99 Million | -12.65 Million | -15.61 Million | -18.95 Million | -26.96 Million |
| Common Stock Repurchased | -11.68 Million | -101.54 Million | - | - | - | - |
| Common Stock Issuance | - | 101.55 Million | - | - | - | - |
| Other Financing Activities | 415.13 Million | 135.82 Million | 75.27 Million | 113.65 Million | 280.89 Million | 650.34 Million |
| Accounts receivables | -405.32 Million | -36.18 Million | 56.64 Million | 488.91 Million | 58.76 Million | 83.02 Million |
| Accounts payables | 252.07 Million | 26.64 Million | 26.83 Million | -486.01 Million | 54.42 Million | -80.91 Million |
| Inventory | -86.45 Million | 18.65 Million | -25.47 Million | 11.09 Million | -14.97 Million | 21.06 Million |
| Other working capital | 3.47 Million | 73.16 Million | -48.37 Million | -13.42 Million | -50.84 Million | -52.91 Million |
| Cash at beginning of period | 8.97 Million | 32.96 Million | 226.79 Million | 150.18 Million | 91.77 Million | 122.88 Million |
| Cash at end of period | 15.91 Million | 8.97 Million | 32.96 Million | 226.79 Million | 150.18 Million | 91.77 Million |
| Capital Expenditure | -468.35 Million | -31.09 Million | -88.87 Million | -107.72 Million | -91.92 Million | -118.07 Million |
| Effect of forex changes on cash | 1.08 Million | 2.27 Million | -960.53 Thousand | -6.09 Million | 467.15 Thousand | 812.9 Thousand |
| Net cash flow / Change in cash | 6.93 Million | -23.99 Million | -193.82 Million | 76.6 Million | 58.41 Million | -31.11 Million |
| Free Cash Flow | -851.65 Million | -95.42 Million | -77.08 Million | 20.58 Million | 163.15 Million | -44.77 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -45.66 Million | -108.85 Million | -30.5 Million | -196.28 Million | -347.73 Million | -44.31 Million |
| Depreciation & Amortization | - | 27.03 Million | 27.03 Million | 98.22 Million | 98.22 Million | -47.13 Million |
| Deferred income taxes | - | - | - | - | -26.71 Million | -7.79 Million |
| Stock-based compensation | - | 2.84 Million | - | 421.96 Thousand | 421.96 Thousand | 2.04 Million |
| Change in working capital | - | -157.73 Million | - | -488.3 Million | -266.42 Million | 52.88 Million |
| Other non-cash items | 25.9 Million | 299.52 Million | -68.16 Million | 317.8 Million | 27.5 Million | -64.8 Million |
| Investing Cash Flow | -20.75 Million | -168.12 Million | -15.03 Million | -481.78 Million | -536.78 Million | -24.76 Million |
| Investments in PPE | -21.64 Million | -168.83 Million | -14.27 Million | -432.4 Million | -468.35 Million | -25.01 Million |
| Acquisitions | 886.2 Thousand | 709.6 Thousand | -803.47 Thousand | -59.28 Million | -49.63 Million | 243.88 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -93.86 Thousand | 36.2 Thousand | 9.91 Million | -21 Million | -20.75 Million |
| Financing Cash Flow | 6.89 Million | 6.92 Million | 131.84 Million | 755.39 Million | 925.94 Million | 141.57 Million |
| Debt repayment | -29.08 Million | -84.38 Million | -47.96 Million | -533.5 Million | -522.87 Million | -49.9 Million |
| Dividends payments | - | -7.36 Million | -2.3 Million | -6.26 Million | -12.06 Million | -587.52 Thousand |
| Common Stock Repurchased | - | -53.84 Million | - | -11.68 Million | -11.68 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 35.97 Million | -77.46 Million | 86.19 Million | 228.15 Million | 415.13 Million | 192.06 Million |
| Accounts receivables | - | -98.06 Million | - | -405.32 Million | -405.32 Million | 57.91 Million |
| Accounts payables | - | - | - | - | 252.07 Million | 1.56 Million |
| Inventory | - | -151.59 Million | - | -86.45 Million | -86.45 Million | -5.02 Million |
| Other working capital | - | 91.92 Million | - | 3.47 Million | 3.47 Million | -1.56 Million |
| Cash at beginning of period | 365.76 Million | 510.24 Million | 16.71 Million | 10.02 Million | 8.97 Million | 1.99 Million |
| Cash at end of period | 325.78 Million | 365.76 Million | 35.21 Million | 15.91 Million | 15.91 Million | 10.02 Million |
| Capital Expenditure | -21.64 Million | -168.83 Million | -14.27 Million | -432.4 Million | -468.35 Million | -25.01 Million |
| Effect of forex changes on cash | - | 3.96 Million | 368.27 Thousand | 837.99 Thousand | 1.08 Million | 341.63 Thousand |
| Net cash flow / Change in cash | -39.97 Million | -144.48 Million | 18.5 Million | 5.88 Million | 6.93 Million | 8.03 Million |
| Free Cash Flow | -41.4 Million | -5.2 Million | -112.94 Million | -700.97 Million | -851.65 Million | -134.12 Million |
0L3I
YORUF
BOMBWIR
336570
LOKESHMACH
GOLKONDA